BiochemistrybioRxivPreprint
Targeting C42 in PKGIα alleviates diastolic dysfunction in HFpEF
Jie Su, Min Zhang, Xiaoping Yang…·Joseph Robert Burgoyne
This study shows that targeting C42 in PKGI with urolithin A reduces diastolic dysfunction and cardiac remodeling in a mouse model of HFpEF and improves heart tissue function in humans.